© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Expert Interviews
Thought-provoking interviews with industry experts on topics critical to the diagnosis, treatment, and prevention of progressive eye health
Harvesting limbal stem cells from healthy eyes to treat corneal blindness
October 25, 2022
Ula V. Jurkunas, MD, discusses a presentation she gave recently at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago on the use of limbal stem cells to treat corneal blindness.
Aerie continues COMET program to study treatment of dry eye
October 21, 2022
Michelle Senchyna, PhD, provided an update of the COMET program and other development activities at Aerie Pharmaceuticals during a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.
Update on TENAYA and LUCERENE clinical trials
October 21, 2022
During a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Rishi Singh, MD, offered highlights of the two-year results of faricimab in a pair of phase 3 clinical trials.
ARMOR study can offer starting point for treatment of patients with serious eye infections, corneal ulcers
October 20, 2022
According to Penny Asbell, MD, FACS, MBA, the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study has identified high levels of in vitro antibiotic resistance among ocular staphylococcal and pneumococcal pathogens, resistance that may affect treatment success. She discussed the program at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.
New optics textbook aims to be a compendium resource for the topic
October 19, 2022
At AAO, Kamran Riaz, MD, discussed the new textbook, "Optics for the New Millennium," which is intended to be a compendium resource for ophthalmologists.
Adaptive cataract surgery system streamlines procedure
October 19, 2022
Harvey Uy, MD, has been using the Ally adaptive cataract treatment system at his clinic in the Philippines, and it is allowing him to be more efficient.
Moving beyond the drop: CEO provides updates on Oyster Point's pipeline
October 18, 2022
Jeff Nau, PhD, MMS, President and CEO of Oyster Point Pharmaceuticals, provides an appraisal of the company's pipeline as well as updates on recent innovations to hit the market.
Durezol studied as treatment option for scleritis
October 15, 2022
Meghan Berkenstock, MD, presented a paper at AAO titled “Effectiveness of Durezol as Additional Agent to Systemic Medications for Treatment of Scleritis,” and shared the highlights in a conversation with Ophthalmology Times.®
Vlog: When it comes to MRI magnets, bigger may be better
October 14, 2022
On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, compare the 1.5 Tesla magnet and the 3.0 Tesla magnet for MRI.
World Cornea Congress spotlights Fuchs dystrophy
October 14, 2022
Kathryn A. Colby, MD, PhD, discusses highlights of the World Cornea Congress, which was held recently in Chicago.